Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
116 studies found for:    "Uterine sarcoma"
Show Display Options
Rank Status Study
1 Unknown  The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
Condition: Uterine Sarcoma
Intervention: Drug: doxorubicin, ifosfamide, cisplatin
2 Recruiting IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
Condition: Uterine Sarcoma
Interventions: Drug: Cabozantinib;   Drug: Placebo
3 Active, not recruiting Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma
Conditions: Soft Tissue Sarcoma;   Uterine Sarcoma
Interventions: Drug: Trabectedin;   Other: Drug: holiday
4 Unknown  Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: ixabepilone;   Other: laboratory biomarker analysis
5 Terminated
Has Results
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: temsirolimus
6 Completed Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Conditions: Recurrent Uterine Sarcoma;   Uterine Leiomyosarcoma
Intervention: Drug: sunitinib malate
7 Completed
Has Results
Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
8 Recruiting Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Other: Clinical Observation;   Drug: Docetaxel;   Drug: Doxorubicin Hydrochloride;   Biological: Filgrastim;   Drug: Gemcitabine Hydrochloride;   Biological: Pegfilgrastim
9 Completed Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
Conditions: Endometrial Adenocarcinoma;   Stage I Uterine Corpus Cancer;   Stage I Uterine Sarcoma;   Stage II Uterine Corpus Cancer;   Stage II Uterine Sarcoma
Interventions: Procedure: Laparoscopic Surgery;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery
10 Recruiting Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
Conditions: Stage IA Uterine Sarcoma;   Stage IB Uterine Sarcoma;   Stage IC Uterine Sarcoma;   Stage IIA Uterine Sarcoma;   Stage IIB Uterine Sarcoma;   Stage IIIA Uterine Sarcoma;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Docetaxel;   Radiation: Internal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: External Beam Radiation Therapy;   Other: Laboratory Biomarker Analysis
11 Terminated Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
Condition: Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: mitomycin C
12 Completed
Has Results
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: sorafenib tosylate
13 Active, not recruiting
Has Results
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Alisertib;   Other: Laboratory Biomarker Analysis
14 Completed Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: Pazopanib Hydrochloride
15 Active, not recruiting
Has Results
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Ixabepilone;   Other: Laboratory Biomarker Analysis
16 Completed Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Docetaxel
17 Completed Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Docetaxel;   Biological: Filgrastim;   Biological: Pegfilgrastim
18 Completed
Has Results
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Carcinosarcoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Thalidomide
19 Completed Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Thalidomide;   Other: Laboratory Biomarker Analysis
20 Completed Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.